Clinical trial
Aerosol Cyclosporine for Prevention of Lung Rejection
NCT00268515 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00268515 |
|---|---|
| Title | Aerosol Cyclosporine for Prevention of Lung Rejection |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Diseases |
| Intervention type | Drug |
| Interventions | cyclosporine, tacrolimus, prednisone, azathioprine |
| Start date | Apr 1, 1998 |
| Completion | Mar 1, 2003 |
| First posted | Dec 22, 2005 |
| Last update posted | May 13, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: